Dudediligence.

OnKure Therapeutics, Inc

OKURNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$11.6MSep ’24−$17.4MDec ’24−$15.9MMar ’25−$15.4MJun ’25−$14.7MSep ’25−$13.5MDec ’25−$15.2MMar ’26−$15.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on filenone on file$0.00none on file
Operating income−$39.8M−$53.8M−$36.9M−$54.4M−$63.0M
Net income−$39.8M−$52.0M−$35.3M−$52.7M−$59.5M
Operating cash flow−$38.0M−$47.4M−$34.5M−$51.1M−$51.8M
Free cash flow−$38.2M−$47.7M−$34.8M−$51.2M−$51.9M
Cash$124.7M$19.9M$29.9M$110.8M$59.0M
Shares outstanding24.5M24.7M33.4M3.4M13.5M